Skip to main content

Bank of New York Mellon Corp

Bank

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in KYMR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$24,721,472
+$8,629,849 QoQ
Shares Held
215,588
+11.6% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in KYMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. KYMR ranks #36 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KYMR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,721,472 215,588
2026-03-31 $16,091,623 193,200
2025-12-31 $14,997,719 192,748
2025-09-30 $8,628,780 152,452
2025-06-30 $5,704,356 130,714
2025-03-31 $3,472,621 126,877
2024-12-31 $5,112,949 127,093
2024-09-30 $5,757,457 121,645
2024-06-30 $4,662,898 156,211
2024-03-31 $5,261,938 130,894
2023-12-31 $3,401,226 133,591
2023-09-30 $1,755,068 126,264
2023-06-30 $2,898,025 126,056
2023-03-31 $28,621,598 965,967
2022-12-31 $24,709,548 989,966
2022-09-30 $22,319,559 1,025,244
2022-06-30 $20,175,592 1,024,662
2022-03-31 $29,039,727 686,194
2021-12-31 $33,695,283 530,718
2021-09-30 $29,421,689 500,880
2021-06-30 $3,326,130 68,580
2021-03-31 $1,489,736 38,336
2020-12-31 $2,496,120 40,260